Ban Mishu Allos

3.2k total citations · 1 hit paper
24 papers, 2.2k citations indexed

About

Ban Mishu Allos is a scholar working on Neurology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ban Mishu Allos has authored 24 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 8 papers in Infectious Diseases and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ban Mishu Allos's work include Peripheral Neuropathies and Disorders (13 papers), Salmonella and Campylobacter epidemiology (7 papers) and Hereditary Neurological Disorders (7 papers). Ban Mishu Allos is often cited by papers focused on Peripheral Neuropathies and Disorders (13 papers), Salmonella and Campylobacter epidemiology (7 papers) and Hereditary Neurological Disorders (7 papers). Ban Mishu Allos collaborates with scholars based in United States, Japan and Australia. Ban Mishu Allos's co-authors include David W. K. Acheson, Irving Nachamkin, Tony W. Ho, Martin J. Blaser, Jean C. Buzby, Tanya Roberts, Patricia M. Griffin, Robert V. Tauxe, Matthew R. Moore and Richard G. Hibbs and has published in prestigious journals such as Annals of Internal Medicine, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

Ban Mishu Allos

23 papers receiving 2.1k citations

Hit Papers

Campylobacter jejuni Infections: Update on Emerging Issue... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ban Mishu Allos United States 13 1.6k 1.3k 332 321 281 24 2.2k
J N Hennessy Canada 15 848 0.5× 573 0.5× 196 0.6× 146 0.5× 63 0.2× 28 1.2k
M. B. Skirrow United Kingdom 18 2.2k 1.3× 1.3k 1.0× 311 0.9× 430 1.3× 36 0.1× 26 2.8k
D H Burr United States 17 959 0.6× 747 0.6× 435 1.3× 168 0.5× 51 0.2× 21 1.4k
Nancy T. Hargrett United States 8 833 0.5× 1.6k 1.3× 1.7k 5.3× 586 1.8× 195 0.7× 10 2.9k
Kathie Grant United Kingdom 35 2.0k 1.2× 832 0.7× 910 2.7× 1.3k 3.9× 164 0.6× 83 3.4k
Andreas E. Zautner Germany 26 910 0.6× 995 0.8× 278 0.8× 123 0.4× 25 0.1× 95 2.2k
Corinne Amar United Kingdom 26 641 0.4× 1.3k 1.0× 129 0.4× 580 1.8× 39 0.1× 61 2.4k
Miriam Koene Netherlands 17 280 0.2× 608 0.5× 141 0.4× 47 0.1× 164 0.6× 47 1.2k
Raimond Lugert Germany 21 614 0.4× 717 0.6× 194 0.6× 79 0.2× 19 0.1× 48 1.6k
Milena M. Awad Australia 23 143 0.1× 1.7k 1.3× 121 0.4× 66 0.2× 219 0.8× 48 2.3k

Countries citing papers authored by Ban Mishu Allos

Since Specialization
Citations

This map shows the geographic impact of Ban Mishu Allos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ban Mishu Allos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ban Mishu Allos more than expected).

Fields of papers citing papers by Ban Mishu Allos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ban Mishu Allos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ban Mishu Allos. The network helps show where Ban Mishu Allos may publish in the future.

Co-authorship network of co-authors of Ban Mishu Allos

This figure shows the co-authorship network connecting the top 25 collaborators of Ban Mishu Allos. A scholar is included among the top collaborators of Ban Mishu Allos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ban Mishu Allos. Ban Mishu Allos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allos, Ban Mishu, et al.. (2020). A Review of β-Lactam–Associated Neutropenia and Implications for Cross-reactivity. Annals of Pharmacotherapy. 55(8). 1037–1049. 18 indexed citations
2.
Allos, Ban Mishu, Amy Fleming, William B. Cutrer, et al.. (2018). Framing Medicine as a Moral Practice: An Introductory Medical School Course. Academic Medicine. 93(9). 1310–1314. 4 indexed citations
3.
Allos, Ban Mishu, Matthew R. Moore, Patricia M. Griffin, & Robert V. Tauxe. (2004). Surveillance for Sporadic Foodborne Disease in the 21st Century: The FoodNet Perspective. Clinical Infectious Diseases. 38(s3). S115–S120. 96 indexed citations
4.
Acheson, David W. K. & Ban Mishu Allos. (2001). Campylobacter jejuni Infections: Update on Emerging Issues and Trends. Clinical Infectious Diseases. 32(8). 1201–1206. 922 indexed citations breakdown →
5.
Misawa, Naoaki, Kumiko Kawashima, Fusao Kondo, Ban Mishu Allos, & Martin J. Blaser. (2001). DNA diversity of the wla gene cluster among serotype HS:19 and non-HS:19 Campylobacter jejuni strains. Journal of Endotoxin Research. 7(5). 349–358. 10 indexed citations
6.
Allos, Ban Mishu. (1998). CAMPYLOBACTER JEJUNI INFECTION AS A CAUSE OF THE GUILLAIN-BARRÉ SYNDROME. Infectious Disease Clinics of North America. 12(1). 173–184. 46 indexed citations
7.
Allos, Ban Mishu, et al.. (1998). Differentiation of Campylobacter jejuni Serotype O19 Strains from Non-O19 Strains by PCR. Journal of Clinical Microbiology. 36(12). 3567–3573. 20 indexed citations
8.
Allos, Ban Mishu, et al.. (1998). Campylobacter jejuni Strains from Patients with Guillain-Barré Syndrome. Emerging infectious diseases. 4(2). 263–268. 30 indexed citations
9.
Buzby, Jean C., Ban Mishu Allos, & Tanya Roberts. (1998). Guillain‐Barré Syndrome Incidence Based on Hospital Discharge Data. The Journal of Infectious Diseases. 178(4). 1228–1228. 1 indexed citations
10.
Buzby, Jean C., Tanya Roberts, & Ban Mishu Allos. (1997). Estimated Annual Costs of Campylobacter-Associated Guillain-Barre Syndrome. RePEc: Research Papers in Economics.
11.
Lang, Dennis, Ban Mishu Allos, & Martin J. Blaser. (1997). Workshop Summary and Recommendations Regarding the Development of Guillain‐Barré Syndrome followingCampylobacterInfection. The Journal of Infectious Diseases. 176(s2). S198–S200. 8 indexed citations
12.
Buzby, Jean C., Ban Mishu Allos, & Tanya Roberts. (1997). The Economic Burden ofCampylobacter‐AssociatedGuillain‐Barré Syndrome. The Journal of Infectious Diseases. 176(s2). S192–S197. 78 indexed citations
13.
Allos, Ban Mishu. (1997). Association betweenCampylobacterInfection and Guillain‐Barré Syndrome. The Journal of Infectious Diseases. 176(s2). S125–S128. 197 indexed citations
15.
Blaser, Martin J., Ban Mishu Allos, & Dennis Lang. (1997). Development of Guillain-BarreSyndrome following Campylobacter Infection. 1 indexed citations
16.
Hibbs, Richard G., et al.. (1996). Experience with the Use of an Investigational F(ab')2 Heptavalent Botulism Immune Globulin of Equine Origin During an Outbreak of Type E Botulism in Egypt. Clinical Infectious Diseases. 23(2). 337–340. 76 indexed citations
17.
Marrie, Thomas J., R. Allan Purdy, Bree Johnston, et al.. (1995). Encephalomyeloradiculopathy of Infectious or Parainfectious Etiology--A New Entity?. Clinical Infectious Diseases. 20(4). 945–953. 9 indexed citations
18.
Allos, Ban Mishu & Martin J. Blaser. (1995). Campylobacter jejuni and the Expanding Spectrum of Related Infections. Clinical Infectious Diseases. 20(5). 1092–1101. 150 indexed citations
19.
Allos, Ban Mishu & Martin J. Blaser. (1995). Re: Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. Journal of Endotoxin Research. 2(4). 237–238. 4 indexed citations
20.
Allos, Ban Mishu & Martin J. Blaser. (1994). Campylobacter jejuni Infection and the Guillain-Barre Syndrome: Mechanisms and Implications. Zentralblatt für Bakteriologie. 281(4). 544–548. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026